0,05. Доказательная медицина от магии до поисков бессмертия

Vedula S. S., Bero L., Scherer R. W., Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use // The New England Journal of Medicine. 2009. № 20. Vol. 361. P. 1963–1971.

Sox H. C., Rennie D. Seeding trials: just say “No” // Annals of Internal Medicine (Editorial). 2008. August 19. Vol. 149. № 4. P. 279–280.

Kuriya B., Schneid E. C., Bell C. M. Quality of pharmaceutical industry press releases based on original research // PLoS ONE. 2008. Vol. 3. № 7, e2828.

Woloshin S., Schwartz L. M. Press releases: translating research into news // JAMA. 2002. Vol. 287. № 21. P. 2856–2858.

Yavchitz A., Boutron I., Bafeta A., Marroun I., Charles P., Mantz J. et al. Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study // PLoS Med. 2012. Vol. 9. № 9, e1001308.

Welch H. G., Black W. C. Overdiagnosis in Cancer // Journal of the National Cancer Institute. 2010. May 5. Vol. 102. № 9. P. 605–613.

Барчук А., Талантов П. Война на опережение. Скрининг не станет очередной панацеей от рака, нужно менять привычки людей // Новая газета. 2018. 17 сентября. № 102.

Marmot M. G., Altman D. G., Cameron D. A., Dewar J. A., Thompson S. G., Wilcox M. The benefits and harms of breast cancer screening: an independent review // British Journal of Cancer. 2013. June 11. Vol. 108. № 11. P. 2205–2240.

Gøtzsche P. C., Nielsen M. Screening for breast cancer with mammography (Review). Cochrane Database of Systematic Reviews. 2011. № 4.

Yaffe M. J., Mainprize J. G. Risk of radiation-induced breast cancer from mammographic screening // Radiology. 2011. January. Vol. 258. № 1. P. 98–105.

WHO position paper on mammography screening. World Health Organization, 2014.

Schroder F. H., Hugosson J., Roobol M. J. et al. Screening and prostate-cancer mortality in a randomized european study // The New England Journal of Medicine. 2009. Vol. 360. № 13. P. 1320–1328.

Draisma G., Boer R., Otto S. J. et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer // Journal of the National Cancer Institute. 2003. June 18. Vol. 95. № 12. P. 868–878.

Gillies D. Hempelian and Kuhnian approaches in the philosophy of medicine: the Semmelweis Case // Studies in history and philosophy of biological and biomedical sciences. 2005. March. Vol. 36. № 1. P. 159–181.

Noakes T. D., Borresen J., Hew-Butler T., Lambert M. I., Jordaan E. Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical review // Epidemiology and infection. 2008. January. Vol. 136. № 1. P. 1–9.

Dunn P. M. Ignac Semmelweis (1818–1865) of Budapest and the prevention of puerperal fever // Archives of disease in childhood. Fetal and neonatal edition. 2005. Vol. 90. № 4, F345–348.

Semmelweis I. The etiology, concept, and prophylaxis of childbed fever. Madison and London: The University of Wisconsin Press, 1983.

Best M., Neuhauser D. Ignaz Semmelweis and the birth of infection control // Quality & safety in health care. 2004. June. Vol. 13. № 3. P. 233–234.

Bridson E. Y. Iatrogenic epidemics of puerperal fever in the 18th and 19th centuries // British journal of biomedical science. 1996. June. Vol. 53. № 2. P. 134–139.

Alper B. S., Hand J. A., Elliott S. G., Kinkade S., Hauan M. J., Onion D. K. et al. How much effort is needed to keep up with the literature relevant for primary care? // Journal of the Medical Library Association. 2004. October. Vol. 92. № 4. P. 429–437.